查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439236

心臟帮浦设备 - 全球市场考量、竞争状况、市场预测 (2030)

Heart Pump Device - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球心臟帮浦设备市场规模预计到2023年将达到27.3亿美元，到2030年将达到63.5亿美元，2024-2030年预测期间复合年增长率为15.16%。心臟泵设备的需求主要是由心血管疾病（CVD）盛行率的增加、老年人口的增加以及各种产品处于研发阶段的公司所推动的。研究发现，心臟帮浦设备对治疗 COVID-19 心臟衰竭病例非常有益，这进一步增加了疫情期间对这些设备的需求。由于缺乏心臟供应商，心臟帮浦成为驱动全球市场扩张的最佳解决方案。然而，发展中市场的泵浦成本高和还款率低等因素预计将抑制市场成长。

心泵设备市场动态

根据美国心臟协会（2022）的数据，2020 年全球约有 2.441 亿人患有冠状动脉心臟病（缺血性心臟病）。

根据英国心臟基金会（2022）提供的数据，2019年全球约有5.5亿人，即每14人中就有1人患有心臟和循环系统疾病，其中包括约2.9亿女性和约2.6亿男性。

上述文件进一步指出，冠状动脉心臟病、週边动脉疾病、中风和心房颤动是2019年全球最常见且流行的心血管疾病。

根据国家卫生组织 (PAHO) (2022) 的数据，心血管疾病每年造成的死亡人数比其他任何疾病都多。2021 年，与心臟病和中风相关的死亡人数占低收入和中等收入国家所有死亡人数的四分之三以上。

增加有关心臟泵设备的研发活动进一步促进了心臟泵设备市场的成长。例如，2022 年 8 月，Abbott宣布，根据 MOMENTUM 3 试验的数据，其 HeartMate 3 心臟帮浦可将心臟衰竭患者的生存期延长至少五年。

因此，上述因素预计将在未来几年推动整个心臟帮浦设备市场的发展。

然而，发展中国家的高泵成本和低还款情况可能成为心泵设备市场成长的限制因素。

心泵设备细分市场分析

在心泵设备市场的产品细分中，属于心室辅助设备类别的左心室辅助设备（LVAD）预计将占据最大份额，是市场上成长最快的细分市场之一。

这主要是由于与 LVAD 相关的益处和应用，以及技术进步、器官捐赠者短缺以及全球心臟衰竭盛行率的增加。

LVAD 旨在透过恢復正常血流来治疗严重心臟衰竭患者。在心臟衰竭患者体内植入 LVAD 可以挽救生命，并为器官移植赢得时间。

LVAD 高度可靠且内建安全系统。

植入 LVAD 后，患者的健康状况有所改善，并且能够恢復/恢復运动和其他日常活动。

LVAD 为严重心臟衰竭患者提供了中长期治疗方案。

因此，所有上述因素预计将推动心臟泵设备市场的成长。

北美预计将主导整个心臟帮浦设备市场。

预计在预测期内，北美将主导整个心臟帮浦设备市场。这是由于该国庞大的心血管疾病（CVD）患者群体、非常强大的产品开发和市场开发市场、较高的消费者认知度以及该地区主要市场参与者的存在，这些被认为是推动这一成长的关键因素。市场成长。

该报告提供了全球心臟帮浦设备市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章心臟泵设备市场报告简介

第二章心臟泵设备市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章心泵设备市场关键因素分析

  • 心泵设备市场驱动因素
    • 心血管疾病（CVD）增加
    • 老年人口增加
    • 多家公司的产品处于管道阶段
  • 心泵设备市场的限制与挑战
    • 泵浦的成本高
    • 发展中国家的低还款状况
  • 心泵设备市场机会
    • 优先选择自调节泵
    • 开发先进、非侵入性、紧凑型设备

第五章心臟泵装置的波特五力分析

第六章 心泵设备市场布局

  • 按产品
    • 心室辅助装置
    • 主动脉内球囊反搏器
    • 完整的人造心臟
  • 按类型
    • 植入式心臟帮浦装置
    • 体外心臟帮浦装置
  • 依治疗方法
    • BT
    • BTC
    • DT
  • 按最终用户
    • 医院
    • 门诊手术中心
    • 其他
  • 按地区
    • 北美心臟帮浦设备市场（2021-2030）
    • 欧洲心臟帮浦设备市场（2021-2030）
    • 亚太地区心臟帮浦设备市场（2021-2030）
    • 其他地区心泵设备市场（2021-2030）

第七章 心泵设备公司及产品简介

  • Abbott Laboratories
  • Abiomed, Inc.
  • Teleflex Incorporated
  • SynCardia Systems, LLC
  • St. Jude Medical Inc.
  • Berlin Heart
  • CARMAT
  • CorWave SA
  • Medtronic Inc.
  • Terumo Heart, Inc.
  • Calon Cardio-Technology Ltd.
  • NovaPump GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Angiodroid srl
  • Getinge AB

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第 11 章关于 DelveInsight

第十二章 免责声明与联络我们

Product Code: DIMDCL0022

Heart Pump Devices Market By Product (Ventricular Assist Devices [Left Ventricular Assist Devices (LVAD), Percutaneous Ventricular Assist Devices (PVAD), Biventricular Ventricular Assist Devices (BIVAD), and Right Ventricular Assist Devices (RVAD)], Intra-Aortic Balloon Pumps, and Total Artificial Hearts), Type (Implanted Heart Pump Device and Extracorporeal Heart Pump Device), Therapy (Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), and Destination Therapy (DT)), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of cardiovascular diseases (CVDs) and increasing research and development activities

The global heart pump devices market was valued at USD 2.73 billion in 2023, growing at a CAGR of 15.16% during the forecast period from 2024 to 2030, to reach USD 6.35 billion by 2030. The demand for heart pump devices is primarily motivated by the increase in cardiovascular disease (CVDs) prevalence, the rise in the geriatric population, and various companies with products in their pipeline phase. Heart Pump devices were found to be extremely beneficial in heart failure cases in COVID-19 which further pushed for the demand for these devices during the pandemic situation. Due to a scarcity of heart suppliers, cardiac pumps are an optimal solution that encourages Global market expansion. Factors such as the high cost of the pump and a low repayment scenario in developing countries are nevertheless projected to inhibit the growth of the market.

Heart Pump Devices Market Dynamics:

According to the American Heart Association 2022, about 244.1 million people were globally living with coronary (ischemic) heart disease in 2020.

As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men.

The source mentioned above further stated that coronary (ischemic) heart disease (200 million cases), peripheral arterial (vascular) disease (110 million cases), stroke (100 million cases), and atrial fibrillation (60 million cases) remained the commonest and prevalent cardiovascular conditions worldwide in 2019.

According to Pan American Health Organization (PAHO) 2022, cardiovascular diseases cause more deaths yearly than any other disease. Heart disease and stroke-related fatalities account for more than three-quarters of all deaths in low- and middle-income nations in 2021.

The increasing number of research and development activities pertaining to heart pump devices is further going to assist in the growth of the heart pump devices market. For example, in August 2022, Abbott based upon data obtained from the MOMENTUM 3 trial announced that its HeartMate 3 heart pump extends the survival of heart failure patients by at least five years.

Therefore, the afore-said factor will propel the overall market of heart pump devices in the upcoming years.

However, the high cost of the pump and low repayment scenario in developing countries may act as a restraint in the growth of the heart pump devices market.

Heart Pump Devices Market Segment Analysis:

Heart Pump Devices by Product (Ventricular Assist Devices [Left Ventricular Assist Devices (LVAD), Percutaneous Ventricular Assist Devices (PVAD), Biventricular Ventricular Assist Devices (BIVAD), and Right Ventricular Assist Devices (RVAD)], Intra-Aortic Balloon Pumps, and Total Artificial Hearts), Type (Implanted Heart Pump Device and Extracorporeal Heart Pump Device), Therapy (Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), and Destination Therapy (DT)), End-User (Hospitals, Ambulatory Surgical Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the heart pump devices market, left ventricular assist devices (LVAD) under the ventricular assist devices category are expected to hold the largest share and are one of the fastest-growing segments in this market.

It is primarily attributed to the advantages and applications associated with LVAD coupled with increasing technological advancements, the scarcity of organ donors, and the increasing prevalence of heart failure globally.

LVAD is intended for the treatment of patients with severe heart failure by restoring normal blood flow. The implantation of LVAD in heart failure patients can be life-saving and buys more time for them till organ transplantation.

LVADs are highly reliable and come with built-in safety systems.

Post implantation of LVAD, patients witness improvement in their health and can return/resume their daily activities including driving, and others.

LVADs offer intermediate to long-term treatment solutions for severe heart failure patients.

Hence, all the above-mentioned factors are expected to drive the segment growth of the heart pump devices market.

North America is expected to dominate the overall Heart Pump Devices Market:

North America is expected to dominate the overall Heart Pump Devices market during the forecast period. This can be ascribed to the presence of a large patient pool suffering from cardiovascular diseases (CVDs), the highly potent market in terms of product development and launches, high consumer awareness, and the presence of local key market players among other factors in the country, driving the market growth.

The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020.

Also, the same source stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent-the damage is done, but the person is not aware of it.

The increasing number of product development activities in the region is further going to accelerate the growth of the heart pump devices market. For example, in August 2021, the US Food and Drug Administration granted a breakthrough device designation to Abiomed's Impella ECP expandable percutaneous heart pump.

Thus, due to the increase in demand for heart pump devices in the region, there will be a subsequent rise in the growth of heart pump devices regional market during the forecast period.

Heart Pump Devices Market Companies:

Some of the key market players operating in the Heart Pump Devices market include Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc. CARMAT, CorWave SA, Medtronic Inc., Terumo Heart, Inc., Calon Cardio-Technology Ltd., NovaPump GmbH, Fresenius Medical Care AG & Co. KGaA, Angiodroid srl, Getinge AB and others.

Recent Developmental Activities in the Heart Pump Devices Market:

In August 2021, the United States Food and Drug Administration (FDA) granted breakthrough device designation to Abiomed's Impella ECP expandable percutaneous Heart Pump. The designation means the FDA will prioritize Impella ECP's regulatory review processes including design iterations, clinical study protocols, and pre-market approval (PMA) application.

In February 2021, CARMAT received FDA approval to conduct an Early Feasibility Study (EFS) of its Total Artificial Heart in the US using BlueSync technology.

In December 2020, Abbott received FDA approval for the updated labeling for the HeartMate 3 Heart Pump to be used in pediatric patients with advanced refractory left ventricular heart failure.

Key Takeaways from the Heart Pump Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Heart Pump Devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Heart Pump Devices Market.

Various opportunities are available for the other competitor in the Heart Pump Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Heart Pump Devices market growth in the coming future?

Target Audience who can be benefited from This Heart Pump Devices Market Report Study

Heart Pump Devices providers

Research organizations and consulting companies

Heart Pump Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Heart Pump Devices

Various End-users want to know more about the Heart Pump Devices Market and the latest technological developments in the Heart Pump Devices market.

Frequently Asked Questions for the Heart Pump Devices Market:

What are Heart Pump Devices?

Heart pump devices are utilized in patients that are suffering from heart issues such as a recent cardiac arrest. They carry out the normal functions of the heart by maintaining regular cardiac circulation and replacing the heart partially or completely. After receiving the blood from the heart's lower chambers, it helps transfer the blood to all the vital organs in the body.

What is the market for Global Heart Pump Devices?

Global Heart Pump Devices Market was valued at USD 2.73 billion in 2023, growing at a CAGR of 15.16% during the forecast period from 2024 to 2030, to reach USD 6.35 billion by 2030.

What are the drivers for Global Heart Pump Devices?

The major drivers driving the demand for Heart Pump Devices are the increasing prevalence of cardiovascular diseases, the rising geriatric population, and new product development by the market players.

What are the key players operating in Global Heart Pump Devices?

Some of the key market players operating in the Heart Pump Devices market include Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc. CARMAT, CorWave SA, Medtronic Inc., Terumo Heart, Inc., Calon Cardio-Technology Ltd., NovaPump GmbH, Fresenius Medical Care AG & Co. KGaA, Angiodroid srl, Getinge AB and others.

What regions have the highest share in the Heart Pump Devices market?

North America is expected to dominate the overall Heart Pump Devices market during the forecast period, 2024 to 2030. This domination is due to the growing demand for advanced technologies in Heart Pump Devices, the increasing chronic disease in the region is driving the regional growth.

Table of Contents

1. Heart Pump Devices Market Report Introduction

2. Heart Pump Devices Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment

3. Regulatory Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Heart Pump Devices Market Key Factors Analysis

  • 4.1. Heart Pump Devices Market Drivers
    • 4.1.1. Rise in cardiovascular diseases (CVDs)
    • 4.1.2. The rise in the geriatric population
    • 4.1.3. Various companies with products in their pipeline phase
  • 4.2. Heart Pump Devices Market Restraints and Challenges
    • 4.2.1. High cost of the pump
    • 4.2.2. Low repayment scenario in developing countries
  • 4.3. Heart Pump Devices Market Opportunities
    • 4.3.1. Preference for self-regulated pumps
    • 4.3.2. Development of non-invasive, compact, and advanced devices

5. Heart Pump Devices Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. Heart Pump Devices Market Layout

  • 6.1. By Product
    • 6.1.1. Ventricular Assist Devices
      • 6.1.1.1. Left Ventricular Assist Devices (LVAD)
      • 6.1.1.2. Percutaneous Ventricular Assist Devices (PVAD)
      • 6.1.1.3. Biventricular Ventricular Assist Devices (BIVAD)
      • 6.1.1.4. Right Ventricular Assist Devices (RVAD)
    • 6.1.2. Intra-Aortic Balloon Pumps
    • 6.1.3. Total Artificial Hearts
  • 6.2. By Type
    • 6.2.1. Implanted Heart Pump Device
    • 6.2.2. Extracorporeal Heart Pump Device
  • 6.3. By Therapy
    • 6.3.1. Bridge-To-Transplant (BTT)
    • 6.3.2. Bridge-To-Candidacy (BTC)
    • 6.3.3. Destination Therapy (DT)
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centers
    • 6.4.3. Others
  • 6.5 By Geography
    • 6.5.1. North America Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.1.1. United States Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.1.2. Canada Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.1.3. Mexico Heart Pump Devices Market in USD million (2021-2030)
    • 6.5.2. Europe Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.2.1. France Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.2.2. Germany Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.2.4. Italy Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.2.5. Spain Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Heart Pump Devices Market in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.3.1. China Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.3.2. Japan Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.3.3. India Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.3.4. Australia Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.3.5. South Korea Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Heart Pump Devices Market in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.4.1. Middle East Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.4.2. Africa Heart Pump Devices Market in USD million (2021-2030)
      • 6.5.4.3. South America Heart Pump Devices Market in USD million (2021-2030)

7. Heart Pump Devices Company and Product Profiles

  • 7.1. Abbott Laboratories
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Abiomed, Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Teleflex Incorporated
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. SynCardia Systems, LLC
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. St. Jude Medical Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Berlin Heart
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. CARMAT
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. CorWave SA
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Medtronic Inc.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Terumo Heart, Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Calon Cardio-Technology Ltd.
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. NovaPump GmbH
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Fresenius Medical Care AG & Co. KGaA
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Angiodroid srl
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Getinge AB
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL View

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Heart Pump Devices Market in Global (2021-2030)
  • Table 3: Heart Pump Devices Market in Global by Product (2021-2030)
  • Table 4: Heart Pump Devices Market in Global by Type (2021-2030)
  • Table 5: Heart Pump Devices Market in Global by Therapy (2021-2030)
  • Table 6: Heart Pump Devices Market in Global by End-User (2021-2030)
  • Table 7: Heart Pump Devices Market in Global by Geography (2021-2030)
  • Table 8: Heart Pump Devices Market in North America (2021-2030)
  • Table 9: Heart Pump Devices Market in the US (2021-2030)
  • Table 10: Heart Pump Devices Market in Canada (2021-2030)
  • Table 11: Heart Pump Devices Market in Mexico (2021-2030)
  • Table 12: Heart Pump Devices Market in Europe (2021-2030)
  • Table 13: Heart Pump Devices Market in France (2021-2030)
  • Table 14: Heart Pump Devices Market in Germany (2021-2030)
  • Table 15: Heart Pump Devices Market in the United Kingdom (2021-2030)
  • Table 16: Heart Pump Devices Market in Italy (2021-2030)
  • Table 17: Heart Pump Devices Market in Spain (2021-2030)
  • Table 18: Heart Pump Devices Market in Rest of Europe (2021-2030)
  • Table 19: Heart Pump Devices Market in Asia-Pacific (2021-2030)
  • Table 20: Heart Pump Devices Market in China (2021-2030)
  • Table 21: Heart Pump Devices Market in Japan (2021-2030)
  • Table 22: Heart Pump Devices Market in India (2021-2030)
  • Table 23: Heart Pump Devices Market in Australia (2021-2030)
  • Table 24: Heart Pump Devices Market in South Korea (2021-2030)
  • Table 25: Heart Pump Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Heart Pump Devices Market in the Rest of the World (2021-2030)
  • Table 27: Heart Pump Devices Market in the Middle East (2021-2030)
  • Table 28: Heart Pump Devices Market in Africa (2021-2030)
  • Table 29: Heart Pump Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Heart Pump Devices Market in Global (2021-2030)
  • Figure 3: Heart Pump Devices Market in Global by Product (2021-2030)
  • Figure 4: Heart Pump Devices Market in Global by Type (2021-2030)
  • Figure 5: Heart Pump Devices Market in Global by Therapy (2021-2030)
  • Figure 6: Heart Pump Devices Market in Global by End-User (2021-2030)
  • Figure 7: Heart Pump Devices Market in Global by Geography (2021-2030)
  • Figure 8: Heart Pump Devices Market in North America (2021-2030)
  • Figure 9: Heart Pump Devices Market in the US (2021-2030)
  • Figure 10: Heart Pump Devices Market in Canada (2021-2030)
  • Figure 11: Heart Pump Devices Market in Mexico (2021-2030)
  • Figure 12: Heart Pump Devices Market in Europe (2021-2030)
  • Figure 13: Heart Pump Devices Market in France (2021-2030)
  • Figure 14: Heart Pump Devices Market in Germany (2021-2030)
  • Figure 15: Heart Pump Devices Market in the United Kingdom (2021-2030)
  • Figure 16: Heart Pump Devices Market in Italy (2021-2030)
  • Figure 17: Heart Pump Devices Market in Spain (2021-2030)
  • Figure 18: Heart Pump Devices Market in the Rest of Europe (2021-2030)
  • Figure 19: Heart Pump Devices Market in Asia-Pacific (2021-2030)
  • Figure 20: Heart Pump Devices Market in China (2021-2030)
  • Figure 21: Heart Pump Devices Market in Japan (2021-2030)
  • Figure 22: Heart Pump Devices Market in India (2021-2030)
  • Figure 23: Heart Pump Devices Market in Australia (2021-2030)
  • Figure 24: Heart Pump Devices Market in South Korea (2021-2030)
  • Figure 25: Heart Pump Devices Market in the Rest of Asia-Pacific (2021-2030)
  • Figure 26: Heart Pump Devices Market in the Rest of the World (2021-2030)
  • Figure 27: Heart Pump Devices Market in the Middle East (2021-2030)
  • Figure 28: Heart Pump Devices Market in Africa (2021-2030)
  • Figure 29: Heart Pump Devices Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER's Five Force Analysis